Share This Video

Injectables in the Treatment of Type 2 Diabetes: A Guide to Overcoming Patient Concerns

In this video, Dr. LaSalle discusses the integration of injectable therapy into a treatment plan for diabetes that minimizes fear and maximizes therapeutic benefit.
James R. LaSalle, DO
Medical Director, Medical Arts Center
Excelsior Springs, Missouri
James R. LaSalle, DO

References:

  1. American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32(suppl 1):S13-S61.
  2. Brod M, Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009;18(1):23-32.
  3. Age-adjusted percentage of adults with diabetes using diabetes medication, by type of medication, United States, 1997-2011. US Centers for Disease Control and Prevention Web site. http://www.cdc.gov/diabetes/statistics/meduse/fig2.htm. Revised November 20, 2012. Accessed October 7, 2013.
  4. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002;26(suppl 3):S18-S24.
  5. Inzucchi SE, Bergenstal RM, Buse JB, et al; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-1379.
  6. Polonsky WH, Jackson RA. What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes. 2004;22(3):147-150.
  7. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28(10):2543-2545.
  8. Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. J Clin Psychol. 2001;57(4):457-478.